 LATHAM, N.Y.--BUSINESS WIRE--AngioDynamics, Inc. NASDAQ: ANGO, a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology today announced that on April 9, 2021, it submitted a 510k application to the United States Food and Drug Administration FDA for the AlphaVac System, an off-circuit, multi-purpose mechanical aspiration thrombectomy device for the treatment of undesirable intravascular material in the venous syst 